Progress in Antibiotic Discovery and Development (S3)
January 1-4, 2027
| Location to be Determined
Cesar de la Fuente, James J. Collins and Ewa Szczurek
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Saturday, January 2, 2027
| 8:00–9:00 AM |
Welcome and Keynote Address |
|
| |
Roy Kishony †, Technion – Israel Institute of Technology
The Future of Antibiotic Resistance |
|
| 9:00–10:45 AM |
Antibiotics AI: Computational & AI-Enabled Antibiotic Discovery |
|
| |
James J. Collins, Broad Institute of MIT & Harvard
AI Approaches for Antibiotic Discovery |
|
| |
Cesar de la Fuente, University of Pennsylvania
Accelerating Antibiotic Discovery Using AI |
|
| |
Ewa Szczurek, Helmholtz Munich
Controllable Generative AI for Antimicrobial Peptides Discovery |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 10:45–11:15 AM |
Panel Discussion 1: Q&A with Drs. Collins, de la Fuente and Szczurek |
|
| 11:15–1:00 PM |
Poster Setup |
|
| 11:15–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Alternative Approaches to Antibiotics |
|
| |
Manuela Raffatellu †, University of California, San Diego
Harnessing Iron Acquisition Machinery to Target Pathogens |
|
| |
Deborah T. Hung †, Broad Institute of MIT & Harvard
Anti-Virulence Approaches to Target Pathogens |
|
| |
Shura Mankin †, University of Illinois
Novel Concepts in Ribosomal Inhibition |
|
| |
Jörg Vogel †, University of Würzburg
The Promises and Challenges of Programmable RNA Antibiotics |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Natural-Product Biosynthesis and Engineering |
|
| |
Gerry D. Wright †, McMaster University
The Natural History of Antibiotic Resistance |
|
| |
Allison Lopatkin †, University of Rochester
Predictive Biology: Understanding and Reversing the Evolution of Antibiotic Resistance |
|
| |
Helen I. Zgurskaya †, University of Oklahoma
Efflux Pumps and Antimicrobial Resistance |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–12:00 PM |
Panel Discussion 2: The Next Generation of Antibiotic Hunters (inspiring new people into the field) |
|
| |
Jo Handelsman †, University of Wisconsin-Madison
|
|
| |
Erin Duffy †, Boston University & CARB-X
|
|
| |
Paul E. Turner †, Yale University
|
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Antibiotic Discovery and Host Immunity |
|
| |
Yifat Merbl †, Weizmann Institute of Science
Immune Proteasomes: An Untapped Source of Encrypted Peptide Antibiotics |
|
| |
Olga Shevchuk †, University Hospital Essen
Production of Encrypted Peptide Antibiotics in Human Kidney Infections |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Frontiers in Non-Traditional Antimicrobials: Phages, Peptides & Beyond |
|
| |
Paul E. Turner †, Yale University
Phage Therapy to Combat Infections by Antibiotic-Resistant Bacterial Pathogens |
|
| |
Rino Rappuoli †, Fondazione Biotecnopolo di Siena
Vaccines against AMR |
|
| |
Man-Wah Tan †, Genentech, Inc.
Novel Inhibitors against Gram-negative Pathogens |
|
| |
Renee Fleeman †, University of Central Florida
Novel Antimicrobial Approaches Against Klebsiella |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 12:30–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–5:50 PM |
Translating Antibiotics into the Clinic |
|
| |
Tommaso Biancalani †, Genentech
Talk Title to be Announced |
|
| |
Erin Duffy †, Boston University & CARB-X
Talk Title to be Announced |
|
| |
David Payne †, GlaxoSmithKline
Talk Title to be Announced |
|
| 5:50–6:20 PM |
Panel Discussion 3: Q&A with Drs. Biancalani and Duffy |
|
| 6:20–7:30 PM |
Machine Learning and Antimicrobial Peptides |
|
| |
Jiangning Song †, Monash University
Machine Learning for Antimicrobial Peptide Design and Discovery |
|
| |
Daniela Kalafatovic †, University of Rijeka
Self-Assembling Peptide Design with Generative AI |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:30–7:45 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
|
| 7:45–8:45 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
